In this video, Hatim Husain, MD, medical oncologist and associate professor of medicine for Moores Cancer Center at UCSD, explores how liquid biopsies are being incorporated into studies as end points to be considered when analyzing how plasma-based testing can impact progression-free survival (PFS) and overall survival (OS).

Learn more by clicking here.